关于 "Cytoskeleton & Motor Proteins" 的结果63+ 个结果
- Amyloid β-Protein (16-20)CAS: 153247-40-6
Amyloid β-Protein (16-20)是一种β-淀粉样蛋白的五个氨基酸片段。
Amyloid β protein - Amyloid β-Protein (10-35)CAS: 237753-66-1
Amyloid β-protein (10-35), YEVHHQKLVFFAEDVGSNKGAIIGLM, was used as a truncated peptide model for the full-length amyloid β-proteins (1-40) and (1-42) in high-resolution structural studies. In contrast to the full-length amyloid β-proteins, amyloid β-protein (10-35) allowed the controlled and reproducible formation of homogeneous fibrils from aqueous solutions of defined pH, ionic strength and soluble peptide concentration necessary for high-resolution structural studies.
Amyloid β protein - Amyloid β-Protein (1-14)CAS: 186319-74-4
The N-terminal Aβ fragments Aβ1-14, Aβ1-15 (H-6368), and Aβ1-16 (H-2958) are elevated in cell media and in CSF in response to γ-secretase inhibitor treatment. The presence of these small peptides is consistent with a catabolic amyloid precursor protein cleavage pathway by β- followed by α-secretase. It has been shown that Aβ1-14, Aβ1-15, and Aβ1-16 increase dose-dependently in response to γ-secretase inhibitor treatment while Aβ1-42 levels are unchanged.
Amyloid β protein - Amyloid β-Protein (1-37)CAS: 186359-67-1
淀粉样蛋白 β-蛋白质 (1-37) 与阿尔茨海默病的简易精神状态检查 (MMSE) 评分中度相关。
Amyloid β protein - Amyloid β-Protein (1-38)CAS: 131438-74-9
Like Aβ (25-35) (H-1192), the Aβ fragment (1-38) destabilizes calcium homeostasis and renders human cortical neurones vulnerable to environmental insults.
Amyloid β protein - Amyloid β-Protein (1-39)CAS: 115427-62-8
Small quantities of Aβ37, 38 and 39 can be detected in CSF together with Aβ40, the most abundant Aβ homolog, Aβ42, and N-terminally truncated amyloid peptides. The relative amounts depend on the variant of Alzheimer's disease. The C-terminally truncated amyloid peptides are also found in amyloid plaques.
Amyloid β protein - Amyloid β-Protein (1-46)CAS: 285554-31-6
Precursor of the secreted amyloid β-protein (1-40) and (1-42). The identification of amyloid-β-protein (1-46) led to the identification of a zeta-cleavage site between the known γ- and ε-cleavage sites within the transmembrane domain of amyloid-β precursor protein (APP).
Amyloid β protein - Amyloid β-Protein (17-40)CAS: 156790-69-1
Cleavage of APP by alpha- and gamma-secretase (i.e. the non-amyloidogenic pathway) yields p3 peptide, a mix of Aβ 17-40 and Aβ 17-42. p3 is a major constituent of diffuse plaques observed in AD brains and pre-amyloid plaques in people affected by Down syndrome.
Amyloid β protein - Amyloid β-Protein (33-42)CAS: 178949-81-0
GLMVGGVVIA, a partial sequence of β-amyloid protein which is used for raising antibodies against Aβ 1-42. Li et al. studied the aggregation behavior of this and other Aβ 1-42 C-terminal fragments.
Amyloid β protein - Amyloid β-Protein (5-42)CAS: 1678415-97-8
Abeta 5-42 is produced from amyloid precursor protein by action of caspases. It is deposited in Alzheimer's disease brain as well, but less prone to aggregation.
Amyloid β protein - Biotinyl-Amyloid β-Protein (1-42)CAS: 1802086-20-9
N-terminally biotin-labeled Aβ42.
Amyloid β protein
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GP10097 | Amyloid β-Protein (1-15) | 183745-81-5 | Peptides | ||
淀粉样蛋白 β-蛋白 (1-15) 是 β-淀粉样蛋白肽的片段。 | |||||
| GA20740 | Amyloid β-Protein (16-20) | 153247-40-6 | Amyloid β protein | ||
Amyloid β-Protein (16-20)是一种β-淀粉样蛋白的五个氨基酸片段。 | |||||
| GA20720 | Amyloid β-Protein (10-35) | 237753-66-1 | Amyloid β protein | ||
Amyloid β-protein (10-35), YEVHHQKLVFFAEDVGSNKGAIIGLM, was used as a truncated peptide model for the full-length amyloid β-proteins (1-40) and (1-42) in high-resolution structural studies. In contrast to the full-length amyloid β-proteins, amyloid β-protein (10-35) allowed the controlled and reproducible formation of homogeneous fibrils from aqueous solutions of defined pH, ionic strength and soluble peptide concentration necessary for high-resolution structural studies. | |||||
| GA20721 | Amyloid β-Protein (1-12) | 142047-91-4 | Amyloid β protein | ||
| GA20722 | Amyloid β-Protein (1-14) | 186319-74-4 | Amyloid β protein | ||
The N-terminal Aβ fragments Aβ1-14, Aβ1-15 (H-6368), and Aβ1-16 (H-2958) are elevated in cell media and in CSF in response to γ-secretase inhibitor treatment. The presence of these small peptides is consistent with a catabolic amyloid precursor protein cleavage pathway by β- followed by α-secretase. It has been shown that Aβ1-14, Aβ1-15, and Aβ1-16 increase dose-dependently in response to γ-secretase inhibitor treatment while Aβ1-42 levels are unchanged. | |||||
| GA20723 | Amyloid β-Protein (11-42) | 157802-70-5 | Amyloid β protein | ||
| GA20724 | Amyloid β-Protein (1-24) | 138648-77-8 | Amyloid β protein | ||
| GA20725 | Amyloid β-Protein (1-37) | 186359-67-1 | Amyloid β protein | ||
淀粉样蛋白 β-蛋白质 (1-37) 与阿尔茨海默病的简易精神状态检查 (MMSE) 评分中度相关。 | |||||
| GA20726 | Amyloid β-Protein (1-38) | 131438-74-9 | Amyloid β protein | ||
Like Aβ (25-35) (H-1192), the Aβ fragment (1-38) destabilizes calcium homeostasis and renders human cortical neurones vulnerable to environmental insults. | |||||
| GA20727 | Amyloid β-Protein (1-39) | 115427-62-8 | Amyloid β protein | ||
Small quantities of Aβ37, 38 and 39 can be detected in CSF together with Aβ40, the most abundant Aβ homolog, Aβ42, and N-terminally truncated amyloid peptides. The relative amounts depend on the variant of Alzheimer's disease. The C-terminally truncated amyloid peptides are also found in amyloid plaques. | |||||
| GA20736 | Amyloid β-Protein (1-43) | 134500-80-4 | Peptides | ||
淀粉样蛋白 β-Protein (1-43) 比久负盛名的 Aβ1-42 更容易聚集并具有更高的毒性。 | |||||
| GA20737 | Amyloid β-Protein (1-46) | 285554-31-6 | Amyloid β protein | ||
Precursor of the secreted amyloid β-protein (1-40) and (1-42). The identification of amyloid-β-protein (1-46) led to the identification of a zeta-cleavage site between the known γ- and ε-cleavage sites within the transmembrane domain of amyloid-β precursor protein (APP). | |||||
| GA20741 | Amyloid β-Protein (16-22) | 153247-41-7 | Amyloid β protein | ||
Self-assembling Aβ sequence. | |||||
| GA20742 | Amyloid β-Protein (17-40) | 156790-69-1 | Amyloid β protein | ||
Cleavage of APP by alpha- and gamma-secretase (i.e. the non-amyloidogenic pathway) yields p3 peptide, a mix of Aβ 17-40 and Aβ 17-42. p3 is a major constituent of diffuse plaques observed in AD brains and pre-amyloid plaques in people affected by Down syndrome. | |||||
| GA20743 | Amyloid β-Protein (20-29) | 311818-43-6 | Amyloid β protein | ||
FAEDVGSNKG. | |||||
| GA20746 | Amyloid β-Protein (33-42) | 178949-81-0 | Amyloid β protein | ||
GLMVGGVVIA, a partial sequence of β-amyloid protein which is used for raising antibodies against Aβ 1-42. Li et al. studied the aggregation behavior of this and other Aβ 1-42 C-terminal fragments. | |||||
| GA20747 | Amyloid β-Protein (3-40) | 157884-70-3 | Amyloid β protein | ||
| GA20749 | Amyloid β-Protein (35-25) | 147740-73-6 | Amyloid β protein | ||
Aβ 25-35 的反向序列,非活性对照。 | |||||
| GA20750 | Amyloid β-Protein (36-38) | 21835-35-8 | Amyloid β protein | ||
| GA20751 | Amyloid β-Protein (37-39) | 20274-89-9 | Amyloid β protein | ||
| GA20752 | Amyloid β-Protein (40-1) | 144409-99-4 | Amyloid β protein | ||
Reverse sequence of Aβ 1-40. | |||||
| GA20755 | Amyloid β-Protein (5-42) | 1678415-97-8 | Amyloid β protein | ||
Abeta 5-42 is produced from amyloid precursor protein by action of caspases. It is deposited in Alzheimer's disease brain as well, but less prone to aggregation. | |||||
| GA20756 | Amyloid β-Protein (6-20) | 183745-82-6 | Amyloid β protein | ||
| GA20824 | Biotinyl-Amyloid β-Protein (1-42) | 1802086-20-9 | Amyloid β protein | ||
N-terminally biotin-labeled Aβ42. | |||||
